Mutation in gelsolin gene in Finnish hereditary amyloidosis by unknown
F
amilial amyloidosis, Finnish type (FAF) (1), also known
as familial amyloid polyneuropathy type IV (2), is an age-
associated systemic amyloidosis with lattice corneal dystrophy
and progressive cranial neuropathy as the principal clinical
manifestations (1, 3). It is found primarily in families residing
in Southeastern Finland (4), but cases have also been reported
from the Netherlands (5), Denmark (6), and the United States
(7-9). The amyloid fibril protein found in these patients is
a low molecular weight degradation fragment of gelsolin
(10-12), an actin-binding and modulating protein with cy-
toplasmic and plasma forms (13, 14). The amyloid protein
starts at a position corresponding to residue 173 of the ma-
ture plasma gelsolin (10, 13) and has an amino acid substitu-
tion (asparagine for aspartic acid) at codon 187 (position 15
of the amyloid protein) (11, 15). We show here that the variant
protein is the result of an abnormality in the gelsolin gene
located on chromosome 9 (16).
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Summary
Familial amyloidosis, Finnish type (FAF), is an autosomal dominant form of familial amyloid
polyneuropathy. The novel amyloid fibril protein found in these patients is a degradation fragment
of gelsolin, an actin-binding protein. We found a mutation (adenine for guanine) at nucleotide
654 of the gelsolin gene in genomic DNA isolated from five FAF patients. This site is polymorphic
since the normal allele was also present in all the patients tested. This mutation was not found
in two unaffected family members and 11 normal controls. The A for G transition causes an
amino acid substitution (asparagine for aspartic acid) that was found at position 15 of the amyloid
protein. The mutation and consequentamino acid substitution may lead to the development ofFAF
High molecular weight genomic DNA was isolated from au-
topsied tissues or lymphocytes of five patients with FAF and 13
unaffected controls.
Specific fragments were amplified using the thermus aquaticus
(Taq) heat-stable DNA polymerase (17). Amplification reactions
in a volume of 100 pl contained 1 Rg of DNA, 0.125 AM ofeach
primer, and 2.5 u of Taq polymerase in reaction buffer (Perkin-
Elmer-Cetus, Norwalk, CT). The samples were subjected to 25
cycles set at 94°C for 1 min to denature the DNA, 56°C for 30 s
to anneal the primers, and 72°C for 1 min to extend the annealed
primers.
The amplified fragments were subcloned into an M13 bacterio-
phage vector and sequenced by the dideoxy chain termination
method (18).
Slot blotswere performedby applying 25 iAlofthe PCRamplified
fragment to nitrocellulose, in duplicate. An oligonucleotide that
contains the mutation was synthesized, 5' labeled with .y-["PJATT
and T4 polynucleotide kinase, and hybridized to the blots. High
stringency washes of the blots demonstrated the existence of the
mutated allele in the DNA samples tested.
Results and Discussion
The amyloid protein isolated from patients with FAF has
an amino acid substitution, asparagine for aspartic acid at
position 15, corresponding to position 187 of the mature
plasma gelsolin (11, 13).
Aspartic acid is encoded by GAC; thus, only a guanine
to adenine transition is necessary to cause the change to
asparagine (AAC). To test the possibility that the mutation
exists at nucleotide 654 (numbering as for the human plasma
gelsolin cDNA [13]), high molecular weight genomic DNA
was isolated from tissues of five unrelated FAF patients. We
amplified a fragment that contains this nucleotide (nucleo-
tides 565-680) in the PCR (17) using oligonucleotides that
were synthesized based on the cDNA sequences of gelsolin
(13) (Fig. 1). The resulting sequences demonstrated that all
five patients had one allele containing a point mutation, at
nucleotide 654, as well as one normal allele (Fig. 1).
In an attempt to facilitate the identification of the muta-
tion in multiple DNA samples, a different approach was taken.
An oligonucleotide containing the mutation (5' TGA AGC
AGT T_GC CAT TGT 3') was hybridized to amplified DNA
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TG GTG GTG CAG ACA CTC TTC CAC GTC AAA GGG CGC CGT GTG GTC CCT CCC ACC
Val Val Val Gln Arg Leu ?ho Glu Val Lys Gly Arg Arg Val Val Arg Ala Thr
157
￿
.173
Ë
GAG GTA CCT GTG TCC TGG GAG AGC TTC MC AAT GGC:CM .:TGC TTC ATC CTC GAG
Glu Val Pro Val Sar Trp Glu Ser Pha Asn Aar C1y ; ;Aïj:Cys Phe Ile Leu Asp
11ati
i
￿
i
CTC CCC AAC AAC ATC CAC CAGTGGTGT CGl TC~ AAG AGC
￿
TwrGAAnG
Leu Gly Aan Aan Ile His Gln Trp Cys Cly Ser Aan Sar Aan Arg Tyr Glu Arg
210
Figure 1 .
￿
The mutation and amino acid substitution found in gelsolin
in FAF patients. The nucleotides and predicted amino acids are numbered
as for plasma gelsolin (13) . Sequences used to synthesize the oligonucleo-
tides are underlined; the NH2 terminus of amyloid protein is indicated
by an arrow ; the intron is indicated by an arrowhead .
fragments . At low stringency (48"C), the oligonucleotide
probe hybridized to all DNA tested (five FAF patients and
11 controls) . However, at high stringency (65GC), onlyDNA
isolated from FAF patients hybridized to the probe (Fig . 2) .
This technique was used to show the absence of the muta-
tion inDNA isolated from lymphocytes of two unaffected
family members (a sister, no. 6 ; and a son, no. 7) of two of
the FAF patients examined (no . 5 and no. 4, respectively)
(Fig. 2) . Our results suggest that the mutation (G to A)
segregates with the disease, and that the slot blot analysis
can be used as a diagnostic assay for prenatal evaluation of
FAF for high risk populations .
Use of another pair of oligonucleotides designed to am-
plify sequences 565-724 resulted in a fragment >1,300 nu-
cleotides long . Sequence analysis revealed the existence of an
intron between nucleotides 680 and 681 (Fig. 1) . The gel-
solin amyloid protein deposited in FAF patients is encoded
by at leasttwo eions, similar to the Alzheimer's disease amyloid
(3 protein (19) .
The guanine to adenine transition causes an amino acid
substitution in a repetitive motif of gelsolin, conservedamong
species (20) . The asparagine for aspartic acid substitution was
found at position 15 of the amyloid protein extracted from
kidney tissue of a second patient (j.A.A .) (15), while the se-
quence of our original patient(V .U .O .) showed both amino
We thank Fran Hitchcock for assistance with manuscript preparation .
Received for publication 18 July 1990 .
1866
￿
Mutation in Gelsolin Gene in Finnish Hereditary Amyloidosis
Figure 2 . Slot blot analysis demon-
strating theexistence ofa point mutation
inDNA isolated from FAF patients (nos.
1-5) and its absence inDNA isolatedfrom
normal control (no. 8) and two unaffected
family members of FAF patients (nos. 6
and 7) . Genomic DNA sequences 565-
680 (Fig. 1) were amplified with the PCR,
blotted in duplicate and washed in low
stringency (laneA) and in highstringency
(lane B) .
acids at this position (11) . Although the aspartic acid found
at this position in amyloid fibrils isolated from one patient
may be due to deamination of asparagine, it is likely that
the normal allele is also expressed in this patient, as is the
case in other forms of hereditary amyloidoses (21, 22) . The
amino acid substitution appears not to exert a significant effect
on the secondary structure of gelsolin ; nevertheless, its bio-
logical consequence can be profound, as shown in some hemo-
globinopathies (23) .
Mutations have been found in genes encoding various
amyloid proteins in familial amyloidoses with an autosomal
dominant mode of inheritance, such as hereditary cerebral
hemorrhage with amyloidoses, Icelandic type (24) and Dutch
type (25), several types of familial amyloid polyneuropathy
(PAP) (26), Gerstmann-Sträussler-Scheinker syndrome (27),
and FAF, described here. Point mutationmay affect the reg-
ulatory mechanisms of expression of the mRNAs or the
post-translational processing of the precursor protein, thus
enhancing amyloid fibril formation and deposition . Abnor-
malities in genes encoding amyloid proteins may indicate that
the precursor molecules themselves play an effective role in
amyloidogenesis, rather than the amyloid being the conse-
quence ofother pathological conditions involving cell damage.
Thus, understanding the mechanisms of amyloid fibril for-
mation and deposition in this familial diseasemay shed light
on the causation of amyloidoses in general .
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